AZN

AstraZeneca PLC

Add to Watchlist

Advanced Chart

68.720

-0.07(-0.102%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

69.370

Open

68.875

VWAP

69.05

Vol

3.21M

Mkt Cap

213.12B

Low

68.615

Amount

221.33M

EV/EBITDA(TTM)

12.88

Total Shares

3.10B

240.30B

EV/OCF(TTM)

17.93

P/S(TTM)

3.92

AstraZeneca PLC is a science-led biopharmaceutical company. It discovers, develops, and commercializes prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal and metabolism, respiratory and immunology and vaccines and immune therapies. Its key marketed oncology products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Zoladex, Faslodex and others. Its rare diseases products include Soliris, Ultomiris, Strensiq and Kanuma. Its biopharmaceuticals products include Farxiga, Crestor, Breztri and others. Its investigational vaccine candidate IVX-A12, which targets both respiratory syncytial virus and human metapneumovirus. Its oncology candidate includes FPI-2265 targeting prostate specific membrane antigen for metastatic castration resistant prostate cancer, which is in a Phase II trial. It also discovers, develops, and manufactures T-cell receptor therapies. Its Eneboparatide is an investigational therapeutic peptide.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2025Q3

FY2025Q2

15.33B

+2.96%

1.037

-0.75%

14.55B

+7.28%

1.107

+6.44%

14.08B

+8.82%

1.104

+11.54%

Estimates Revision

The market is revising Upward the revenue expectations for AstraZeneca PLC (AZN) for FY2025, with the revenue forecasts being adjusted by 0.52% over the past three months. During the same period, the stock price has changed by 2.72%.

Revenue Estimates for FY2025

Revise Upward

+0.52%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+102.01%

In Past 3 Month

Stock Price

Go Up

+2.72%

In Past 3 Month

6 Analyst Rating

25.15% Upside

Wall Street analysts forecast AZN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AZN is 86.00 USD with a low forecast of 75.00 USD and a high forecast of 97.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

6 Buy

0 Hold

0 Sell

Strong Buy

25.15% Upside

Current: 68.720

Low

75.00

Averages

86.00

High

97.00

25.15% Upside

Current: 68.720

Low

75.00

Averages

86.00

High

97.00

Berenberg

Buy

maintain

$93 -> $99

2025-07-09

Reason

Berenberg

Price Target

$93 -> $99

2025-07-09

maintain

Buy

Reason

Berenberg raised the firm's price target on AstraZeneca to $99 from $93 and keeps a Buy rating on the shares. The firm increased its 2030 revenue forecast by 3% to $79B, ahead of consensus, saying the company has seen "substantial pipeline progress already this year." AstraZeneca shares should price in a larger pipeline valuation, the analyst tells investors in a research note.

Berenberg

Luisa Hector

Buy

maintain

$93 -> $97

2025-07-09

Reason

Berenberg

Luisa Hector

Price Target

$93 -> $97

2025-07-09

maintain

Buy

Reason

Berenberg analyst Luisa Hector raised the firm's price target on AstraZeneca to $97 from $93 and keeps a Buy rating on the shares. The firm increased its 2030 revenue forecast by 3% to $79B, ahead of consensus, saying the company has seen "substantial pipeline progress already this year." AstraZeneca shares should price in a larger pipeline valuation, the analyst tells investors in a research note.

UBS

Matthew Weston

Hold

Strong Buy

Upgrades

n/a

2025-02-13

Reason

UBS

Matthew Weston

Price Target

n/a

2025-02-13

Upgrades

Hold

Strong Buy

Reason

UBS

Matthew Weston

Strong Sell

Hold

Upgrades

n/a

2024-11-20

Reason

UBS

Matthew Weston

Price Target

n/a

2024-11-20

Upgrades

Strong Sell

Hold

Reason

Erste Group

Hans Engel

Hold

Strong Buy

Upgrades

n/a

2024-09-11

Reason

Erste Group

Hans Engel

Price Target

n/a

2024-09-11

Upgrades

Hold

Strong Buy

Reason

TD Cowen

Steve Scala

Strong Buy

Maintains

$90 → $95

2024-08-12

Reason

TD Cowen

Steve Scala

Price Target

$90 → $95

2024-08-12

Maintains

Strong Buy

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for AstraZeneca PLC (AZN.O) is 14.90, compared to its 5-year average forward P/E of 18.10. For a more detailed relative valuation and DCF analysis to assess AstraZeneca PLC 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Undervalued

5Y Average PE

18.10

Current PE

14.90

Overvalued PE

21.11

Undervalued PE

15.08

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Undervalued

5Y Average EV/EBITDA

14.26

Current EV/EBITDA

11.93

Overvalued EV/EBITDA

15.83

Undervalued EV/EBITDA

12.70

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Undervalued

5Y Average PS

4.28

Current PS

3.67

Overvalued PS

4.71

Undervalued PS

3.85

Financials

Annual

Quarterly

FY2025Q1

YoY :

+7.17%

13.59B

Total Revenue

FY2025Q1

YoY :

+14.04%

3.83B

Operating Profit

FY2025Q1

YoY :

+33.52%

2.93B

Net Income after Tax

FY2025Q1

YoY :

+33.57%

1.87

EPS - Diluted

FY2025Q1

YoY :

+188.60%

2.81B

Free Cash Flow

FY2025Q1

YoY :

+1.06%

83.51

Gross Profit Margin - %

FY2025Q1

YoY :

-100.00%

N/A

FCF Margin - %

FY2025Q1

YoY :

+25.07%

21.50

Net Margin - %

FY2025Q1

YoY :

-100.00%

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Hedge Fund

Hedge Funds areBuying! The buying amount has increased 166.61% over the last quarter.

Sold

0-3

Months

4.7M

Volume

3-6

Months

128.6K

Volume

6-9

Months

5.6M

Volume

0-12

Months

3.8M

Volume

Bought

0-3

6.8M

Volume

Months

3-6

2.5M

Volume

Months

6-9

10.9M

Volume

Months

0-12

8.2M

Volume

Months

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

16.0K

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

8.0K

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

AZN News & Events

Events Timeline

2025-07-21 (ET)

2025-07-21

17:39:03

New

AstraZeneca announces $50B of investment in U.S. by 2030

2025-07-21

07:10:05

AstraZeneca announces FLAURA2 study shows improvement in secondary endpoint

2025-07-21

06:20:41

AstraZeneca announces OS analysis of FLAURA2 Phase III trial of Tagrisso

News

9.0

07-21Benzinga

PinnedAstraZeneca's Multi-Billion Dollar Cancer Drug Tagrisso Improves Overall Survival In Patients With Advanced Lung Cancer

9.0

07-21SeekingAlpha

PinnedAstraZeneca reports positive results from Tagrisso combo trial

8.5

07-21WSJ

PinnedAstraZeneca Plans to Invest $50 Billion in U.S. by 2030

People Also Watch

SoFi Technologies Inc

Alibaba Group Holding Ltd

Advanced Micro Devices Inc

Rivian Automotive Inc

FAQ

What is AstraZeneca PLC (AZN) stock price today?

The current price of AZN is 68.72 USD — it has decreased -0.1 % in the last trading day.

AZN

Market Estimates

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Trading Trends

AZN News & Events

Events Timeline

News

People Also Watch

FAQ

What is AstraZeneca PLC (AZN) stock price today?

What is AstraZeneca PLC (AZN)'s business?

What is the price predicton of AZN Stock?

What is AstraZeneca PLC (AZN)'s revenue for the last quarter?

What is AstraZeneca PLC (AZN)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for AstraZeneca PLC (AZN)'s fundamentals?

How many employees does AstraZeneca PLC (AZN). have?

What is AstraZeneca PLC (AZN) market cap?